All blog items

Two Duke Scholars Receive North Carolina's Highest Honor

Two Duke faculty members will be honored Thursday with the state’s highest civilian honor, the North Carolina Award. Governor Roy Cooper will present the award to Timothy B. Tyson for literature and to Blake S. Wilson for science.

Six PGC faculty named on this year's 'Highly Cited Researchers' list

Peak achievement in the sciences isn’t measured by stopwatches or goals scored, it goes by citations – the number of times other scientists have referenced your findings in their own academic papers. A high number of citations is an indication that a particular work was influential in moving the field forward.

One month before shutting down his lab, Paul Modrich looks back on his pathway to the Nobel

An interview with Dr. Paul Modrich, James B. Duke Professor of Biochemistry and Professor of Chemistry at Duke University. Dr. Modrich was awarded the 2015 Nobel Prize for Chemistry jointly with Tomas Lindahl of the Francis Crick Institute and Clare Hall Laboratory in the UK, and Aziz Sancar of University of North Carolina, Chapel Hill, for mechanistic studies of DNA repair.

93-Year-Old Joins Duke CTSI Study to Help Solve Kidney Disease Mystery in People of African Ancestry

At age 93, Pearl Asbury joined a study at the Duke CTSI office in Kannapolis at the North Carolina Research Campus to better understand kidney disease in people of African ancestry. “I always wanted to be involved in a study just for Afro-Americans. It is wonderful because for so much of our history, our health has not been understood,” said Asbury, who became the 100th person to enroll. “At 93, it might not help me, but it might help my children, grandchildren and great-grandchildren.”

Duke Health designated a NORD Rare Disease Center of Excellence

The National Organization for Rare Disorders (NORD) has designated the Duke Health Rare Disease Center as a NORD Rare Disease Center of Excellence, joining a highly select group of 31 medical centers, nationwide, as part of an innovative network seeking to expand access and advance care and research for rare disease patients in the United States.